Mutations in Sodium Channel β1- and β2-Subunits Associated With Atrial Fibrillation

Circulation: Arrhythmia and Electrophysiology

Volumn 2, Issue 3, 2009, Pages 268-275

  Watanabe, Hiroshi ^a,b   Darbar, Dawood ^a   Kaiser, Daniel W ^a   Jiramongkolchai, Kim ^a   Chopra, Sameer ^a   Donahue, Brian S ^a   Kannankeril, Prince J ^a   Roden, Dan M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Arrhythmia; Atrial fibrillation; Electrophysiology; Genetics; Mutations; Sodium channel

Indexed keywords

SODIUM CHANNEL; SODIUM CHANNEL BETA1; SODIUM CHANNEL BETA2; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; BRUGADA SYNDROME; CARDIOVASCULAR DISEASE; CHANNEL GATING; CHO CELL; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; GENE; GENE MUTATION; GENETIC CONSERVATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART ATRIUM FIBRILLATION; HEART MUSCLE CONDUCTION DISTURBANCE; HETEROLOGOUS EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SCN1B GENE; SCN2B GENE; SCN5A GENE; SODIUM CURRENT; ST SEGMENT ELEVATION; WILD TYPE;

ADULT; ANIMALS; ATRIAL FIBRILLATION; CHO CELLS; CRICETINAE; CRICETULUS; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70349451838     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.108.779181     Document Type: Article

References (37)

1. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004; 292:2471-2477.
2. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005; 105:315-318.
3. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, Aizawa Y. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008; 117:1255-1260.
4. Fatkin D, Otway R, Vandenberg JI. Genes and atrial fibrillation: a new look at an old problem. Circulation. 2007; 116:782-792.
5. Darbar D. Genetics of atrial fibrillation: rare mutations, common polymorphisms, and clinical relevance. Heart Rhythm. 2008; 5:483- 486.
6. Zhang X, Chen S, Yoo S, Chakrabarti S, Zhang T, Ke T, Oberti C, Yong SL, Fang F, Li L, de la Fuente R, Wang L, Chen Q, Wang QK. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell. 2008; 135:1017-1027.
7. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, Jonasdottir A, Baker A, Thorleifsson G, Kristjansson K, Palsson A, Blondal T, Sulem P, Backman VM, Hardarson GA, Palsdottir E, Helgason A, Sigurjonsdottir R, Sverrisson JT, Kostulas K, Ng MC, Baum L, So WY, Wong KS, Chan JC, Furie KL, Greenberg SM, Sale M, Kelly P, MacRae CA, Smith EE, Rosand J, Hillert J, Ma RC, Ellinor PT, Thorgeirsson G, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007; 448:353-357.
8. Meadows LS, Isom LL. Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes. Cardiovasc Res. 2005; 67:448-458.
9. Abriel H, Kass RS. Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins. Trends Cardiovasc Med. 2005; 15:35-40. (Pubitemid 40417543)
10. Terrenoire C, Simhaee D, Kass RS. Role of sodium channels in propagation in heart muscle: how subtle genetic alterations result in major arrhythmic disorders. J Cardiovasc Electrophysiol. 2007; 18:900 -905.
11. Medeiros-Domingo A, Kaku T, Tester DJ, Iturralde-Torres P, Itty A, Ye B, Valdivia C, Ueda K, Canizales-Quinteros S, Tusie-Luna MT, Makielski JC, Ackerman MJ. SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation. 2007; 116:134 -142.
12. Watanabe H, Koopmann TT, Le Scouarnec S, Yang T, Ingram CR, Schott JJ, Demolombe S, Probst V, Anselme F, Escande D, Wiesfeld AC, Pfeufer A, Kaab S, Wichmann HE, Hasdemir C, Aizawa Y, Wilde AA, Roden DM, Bezzina CR. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest. 2008; 118:2260 -2268.
13. Darbar D, Kucera G, Stubblefield T, Wang J, George AL, Roden DM. Cardiac Sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation. 2008; 117:1927-1935.
14. Pretorius M, Donahue BS, Yu C, Greelish JP, Roden DM, Brown NJ. Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass. Circulation. 2007; 116:I1-I7.
15. Warsy I, Norris K, Roden D, Kannankeril P. Ibutilide-induced QT Prolongation varies markedly among individuals in a gender and exerciseindependent fashion. Circulation. 2004; 110:623.
16. Qin N, D'Andrea MR, Lubin ML, Shafaee N, Codd EE, Correa AM. Molecular cloning and functional expression of the human sodium channel beta1B subunit, a novel splicing variant of the beta1 subunit. Eur J Biochem. 2003; 270:4762- 4770.
17. Beldner S, Lin D, Marchlinski FE. Flecainide and propafenone induced ST-segment elevation in patients with atrial fibrillation: clue to specificity of Brugada-type electrocardiographic changes. Am J Cardiol. 2004; 94:1184-1185.
18. Junttila MJ, Raatikainen MJ, Perkiomaki JS, Hong K, Brugada R, Huikuri HV. Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur Heart J. 2007; 28:463- 468.
19. 2+-channel beta1 subunit gene SCN1B. Nat Genet. 1998; 19:366-370.
20. Scheffer IE, Harkin LA, Grinton BE, Dibbens LM, Turner SJ, Zielinski MA, Xu R, Jackson G, Adams J, Connellan M, Petrou S, Wellard RM, Briellmann RS, Wallace RH, Mulley JC, Berkovic SF. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain. 2007; 130:100 -109.
21. Lopez-Santiago LF, Meadows LS, Ernst SJ, Chen C, Malhotra JD, McEwen DP, Speelman A, Noebels JL, Maier SK, Lopatin AN, Isom LL. Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. J Mol Cell Cardiol. 2007; 43:636-647.
22. Dhar Malhotra J, Chen C, Rivolta I, Abriel H, Malhotra R, Mattei LN, Brosius FC, Kass RS, Isom LL. Characterization of sodium channel alpha- and beta-subunits in rat and mouse cardiac myocytes. Circulation. 2001; 103:1303-1310.
23. Johnson D, Bennett ES. Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. J Biol Chem. 2006; 281:25875-25881.
24. Maier SK, Westenbroek RE, Chen C, Isom LL, Maass AH, Catteral WA, Scheuer T. Knock out of the β-subunit of voltage-gated sodium channels causes arrhythmias and disarrangement of sodium channel β-subunits in the heart. Heart Rhythm. 2006; 3:S33-S34.
25. Isom LL. Sodium channel beta subunits: anything but auxiliary. Neuroscientist. 2001; 7:42-54.
26. 2+ channel inactivation by the beta 1 subunit: a deletion analysis. Pflugers Arch. 1995; 431:186 -195.
27. 2+ channel function in the extracellular domain of the beta1 subunit. J Biol Chem. 1998; 273:3954 -3962.
28. McCormick KA, Srinivasan J, White K, Scheuer T, Catterall WA. The extracellular domain of the beta1 subunit is both necessary and sufficient for beta1-like modulation of sodium channel gating. J Biol Chem. 1999; 274:32638 -32646.
29. 2+ channels interact with different molecular regions of the beta1 subunit. J Gen Physiol. 2002; 120:887- 895.
30. McNair WP, Ku L, Taylor MR, Fain PR, Dao D, Wolfel E, Mestroni L. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation. 2004; 110:2163-2167.
31. Ellinor PT, Nam EG, Shea MA, Milan DJ, Ruskin JN, Macrae CA. Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm. 2007; 19:19.
32. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002; 415:219 -226.
33. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science. 2003; 299:251-254.
34. Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y, Liang B, Lin J, Liu Y, Liu B, Zhou Q, Zhang D, Wang R, Ma N, Su X, Niu K, Pei Y, Xu W, Chen Z, Wan H, Cui J, Barhanin J. Identification of a KCNE2 gain-offunction mutation in patients with familial atrial fibrillation. Am J Hum Genet. 2004; 75:899 -905.
35. Xia M, Jin Q, Bendahhou S, He Y, Larroque MM, Chen Y, Zhou Q, Yang Y, Liu Y, Liu B, Zhu Q, Zhou Y, Lin J, Liang B, Li L, Dong X, Pan Z, Wang R, Wan H, Qiu W, Xu W, Eurlings P, Barhanin J. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun. 2005; 332:1012-1019.
36. Eckardt L, Kirchhof P, Loh P, Schulze-Bahr E, Johna R, Wichter T, Breithardt G, Haverkamp W, Borggrefe M. Brugada syndrome and supraventricular tachyarrhythmias: a novel association? J Cardiovasc Electrophysiol. 2001; 12:680-685.
37. Monte CP, Arends JB, Tan IY, Aldenkamp AP, Limburg M, de Krom MC. Sudden unexpected death in epilepsy patients: risk factors: a systematic review. Seizure. 2007; 16:1-7.